Bribery and Corruption in Pharma: President of the EHFCN Speaks Out
Contributor:
Helen Winsor
Posted: 10/28/2010 12:00:00 AM EDT | 0
Posted: 10/28/2010 12:00:00 AM EDT | 0
|
Paul Vincke, President of the European Healthcare Fraud and Corruption Network (EHFCN), and a civil servant at the Ministry of Health in Belgium, outlines recent developments in anti-corruption and bribery legislation in the pharmaceuticals industry. To listen to the podcast now go to
-
Health Technology Assessment Climbs Up the European Agenda due to Lack of Resources -
Achieving Execution Excellence through Lean, Six Sigma and ToC -
eCTD Transforms Pharma -
It's All in the Timing: Developing Innovative Marketing Strategies for Success in Asian Markets -
Addressing Key Challenges in Designing Next Generation Devices -
AstraZeneca: Discovering Drugs Through Partnerships -
Embracing eCTDs and Electronic Submissions -
The Clinical Trials Process -
Getting a Handle on PK Parameters -
Ironing Out Inconsistencies with GCP Auditing
* = required.
Not a member yet? Sign up
Events of Interest
-
Social Media in Pharma Summit: The Web's Largest Online Social Media in Pharma Conference
August 4, 2011
Register Now -
Breakthroughs in CRO Customer Service
February 23, 2012
Register Now -
Drive Successful Commercial Product Launches through Effective Key Packaging
February 7, 2013
Register Now -
Guarantee GDP- Compliant Cool Chain Logistics for Pharmaceuticals to CEE & CIS Countries
January 16, 2013
Register Now




Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!